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Authors’ reply
We thank Stian Orlien and colleagues 
for raising attention to the issue 
of khat use as a recreational drug 
in sub-Saharan Africa in response 
to our Comment.1 Although we 
mentioned the fact that traditional 
herbal medicine could contribute to 
the burden of cirrhosis in this region, 
as the use of khat is associated with a 
substantial increase in liver fibrosis,2 
we do not think that the available 
evidence shows that khat is a major 
contributor to chronic liver disease. 
Khat is used in parts of east Africa, 
including Djibouti, Ethiopia, Somalia, 
Somaliland, Kenya, Sudan, Uganda, 
and Madagascar. Apart from its long-
standing popularity as a recreational 
drug, it can be used for the treatment 
of erectile dysfunction, malaria, 
influenza, vomiting, and headache.3 
The Central African Republic, Gabon, 
and Côte d’Ivoire were in the top 
10% of countries for cirrhosis-related 
deaths in 2010 but khat use is 
uncommon in west or central Africa.4
The question of khat’s liver toxicity is 
complex. It contains numerous com-
pounds, including alkaloids, ter pen-
oids, flavonoids, sterols, glycosides, 
tannins, amino acids, vitamins, 
and minerals.5 Research into the 
deleterious effects of khat has largely 
concentrated on the pharmacological 
effects of cathinone and cathine 
on the cardiovascular system and 
CNS, and studies on possible liver 
toxicity in humans are restricted 
to Ethiopia and Somaliland and to 
reports from western Europe almost 
exclusively involving Somali men. 
Additional research is necessary 
to establish the prevalence of liver 
toxicity in people who chew khat in 
Ethiopia versus Djibouti (where liver 
toxicity is apparently not observed)6 
and Yemen (which has the highest 
proportion of users worldwide),7 and 
in Kenya, Uganda, and Madagascar, 
where studies have not been done. 
Also necessary is investigating the 
mechanisms and progression of liver 
damage induced by khat, the effects 
of gender (khat toxicity is observed 
much more frequently in males)8 and 
genetics (genetic variants in CYP2D6 
might play a role in liver toxicity),9 and 
the contribution of other compounds 
found in khat and of contaminating 
herbicides and pesticides to liver 
disease.10 
Current evidence shows that 
hepatitis viruses and alcohol are the 
main contributors to the incidence of 
liver cirrhosis throughout sub-Saharan 
Africa1 and efforts should continue to 
curb their effects.
We declare no competing interests.
Copyright © 2019 The Author(s). Published by 
Elsevier Ltd. This is an Open Access article under the 
CC BY 4.0 license.
*Sandro Vento, Bartholomew Dzudzor, 
Francesca Cainelli, Kenneth Tachi
sandro.vento@nu.edu.kz 
Department of Medicine, School of Medicine, 
Nazarbayev University, Astana, Kazakhstan (SV, FC); 
University Medical Center, Astana 010000, 
Kazakhstan (SV); Department of Medical 
Biochemistry, College of Health Sciences, School of 
Biomedical and Allied Health Sciences, University of 
Ghana, Accra, Ghana (BD); and Department of 
Medicine and Therapeutics, College of Health 
Sciences, School of Medicine and Dentistry, 
University of Ghana, Accra, Ghana (KT)
1 Vento S, Dzudzor B, Cainelli F, Tachi K. 
Liver cirrhosis in sub-Saharan Africa: neglected, 
yet important. Lancet Glob Health 2018; 
6: e1060–61.
2 Orlien SMS, Ismael NY, Ahmed TA, et al. 
Unexplained chronic liver disease in Ethiopia: 
a cross-sectional study. BMC Gastroenterol 
2018; 18: 27.
3 WHO. Assessement of khat (Catha edulis 
Forsk). 2006. https://www.who.int/medicines/
areas/quality_safety/4.4KhatCritReview.pdf 
(accessed Oct 25, 2018).
4 Acuda W, Othieno CJ, Obondo A, Crome IB. 
The epidemiology of addiction in sub-Saharan 
Africa: a synthesis of reports, reviews, and 
original articles. Am J Addict 2011; 20: 87–99.
5 Kalix P, Braenden O. Pharmacological aspects 
of the chewing of khat leaves. Pharmacol Rev 
1985; 37: 149–64.
6 Coton T, Simon F, Oliver M, Kraemer P. 
Hepatotoxicity of khat chewing. Liver Int 2011; 
31: 434.
7 Al-Mugahed L. Khat chewing in Yemen: 
turning over a new leaf. Bull World Health Organ 
2008; 86: 741–42.
8 Orlien SMS, Sandven I, Berhe NB, et al. 
Khat chewing increases the risk for developing 
chronic liver disease: a hospital-based 
case-control study. Hepatology 2018; 
68: 248–57.
9 Sharma A, Orlien SMS, Abdosh AT, et al. 
PWE-082 genetic variants in CYP2D6 and the 
propensity to chronic liver disease in men 
chewing khat. Gut 2018; 67: A113.
10 Al-Akwa AA, Shaher M, Al-Akwa S, Aleryani SL. 
Free radicals are present in human serum of 
Catha edulis Forsk (khat) abusers. 
J Ethnopharmacol 2009; 125: 471–73.
